Institution: | 1. School of Veterinary Science, Massey University, University Avenue, Palmerston North, 4474, New Zealand;2. Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, 2001 South Lincoln Avenue, Urbana, Illinois, 61802 USA
Contribution: Investigation, Writing - review & editing;3. IDEXX Laboratories, Massey University, University Avenue, Palmerston North, 4474 New Zealand
Contribution: Investigation, Writing - review & editing;4. Animal Cancer Centre, Ontario Veterinary College, University of Guelph, 36 College Avenue West, Guelph, Ontario, N1G 2W1 Canada |
Abstract: | This report describes two cases of feline anal sac squamous cell carcinoma. Cat 1 was managed with a multimodal approach combining surgical resection, radiation therapy and systemic therapy (toceranib phosphate; Palladia™) until local recurrence was identified at 236 days postsurgery. At that time, the cat received carboplatin. With the tumour being progressive, the cat was euthanased 552 days post initial surgery. Cat 2 was managed palliatively with a non-steroidal anti-inflammatory (meloxicam) and supportive medications. Unfortunately, with further decline in quality of life following initial diagnosis, the cat was euthanased 28 days later. Squamous cell carcinoma should be considered as a possible differential diagnosis when a cat is presented for investigation of an anal sac mass. |